Informação da revista
Vol. 35. Núm. 5.
Páginas 313-314 (Maio 2016)
Partilhar
Partilhar
Baixar PDF
Mais opções do artigo
Vol. 35. Núm. 5.
Páginas 313-314 (Maio 2016)
Image in Cardiology
Open Access
Left heart failure, a challenging diagnosis in cardiology
Insuficiência cardíaca esquerda, um desafio diagnóstico em cardiologia
Visitas
5065
Miryan Cassandraa,
Autor para correspondência
m.cassandra.soares@gmail.com

Corresponding author.
, Inês Almeidaa, Rogério Teixeiraa, Joana Trigob, Marco Costaa, Lino Gonçalvesa
a Serviço de Cardiologia do Centro Hospitalar e Universitário de Coimbra – Hospital Geral, Faculdade de Medicina da Universidade de Coimbra, Coimbra, Portugal
b Serviço de Cardiologia do Centro Hospitalar de Trás-os-Montes e Alto Douro, EPE – Hospital de S. Pedro, Vila Real, Portugal
Este item recebeu

Under a Creative Commons license
Informação do artigo
Texto Completo
Baixar PDF
Estatísticas
Figuras (3)
Mostrar maisMostrar menos
Texto Completo

Patent ductus arteriosus (PDA) is one of the most common congenital heart defects, and causes left ventricular volume overload. However, it is a rare finding among adults due to the lack of symptoms related to its small size, and it is not usually associated with other congenital lesions.

A 53-year-old woman was referred for percutaneous closure of a PDA. She had undergone a secundum atrial septal defect (ASD) closure in 2007, detected after a cryptogenic stroke. After this procedure, her clinical history was remarkable for fatigue, dyspnea and orthopnea with New York Heart Association (NYHA) functional class III, and a continuous murmur was heard over the left sternal border. A routine transthoracic echocardiogram performed in 2013 revealed a continuous flow from the aorta towards the pulmonary artery, with left-sided chamber dilation (ejection fraction 50%) and normal pulmonary artery pressure. The device previously implanted at the atrial septum was correctly positioned and without residual shunt (Figure 1). The PDA was closed by placing an Amplatzer™ Duct Occluder guided by fluoroscopy and intracardiac echocardiography (Figure 2). The procedure was uneventful. The 12-month follow-up showed significant clinical improvement (NYHA functional class II), no residual shunt, and normal left chamber dimensions (Figure 3).

Figure 1.

Transthoracic echocardiogram (parasternal short-axis view): color Doppler displays a continuous turbulent flow from the aorta to the left branch of the pulmonary artery, consistent with a patent ductus arteriosus.

(0,08MB).
Figure 2.

Fluoroscopy during percutaneous patent ductus arteriosus closure: left, a continuous flow can be seen from the aorta to the pulmonary artery (yellow arrow); center, during device placement (yellow arrow); right, after the procedure the device is properly positioned with no residual shunt (yellow arrow).

(0,06MB).
Figure 3.

Transthoracic echocardiogram after patent ductus arteriosus closure (parasternal short-axis view): left, an image consistent with the closure device (yellow arrow); right, on color Doppler the turbulent flow is no longer seen.

(0,08MB).

In this case, the association with an ASD may have delayed the clinical manifestations of the PDA, as the previous left-to-right shunt probably compensated for the left ventricular volume overload. It is crucial to perform a complete high-quality echocardiogram in such patients with congenital heart disease, in order to screen for associated anomalies.

Ethical disclosuresProtection of human and animal subjects

The authors declare that no experiments were performed on humans or animals for this study.

Confidentiality of data

The authors declare that no patient data appear in this article.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Conflicts of interest

The authors have no conflicts of interest to declare.

Copyright © 2016. Sociedade Portuguesa de Cardiologia
Idiomas
Revista Portuguesa de Cardiologia
Opções de artigo
Ferramentas
en pt

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Ao assinalar que é «Profissional de Saúde», declara conhecer e aceitar que a responsável pelo tratamento dos dados pessoais dos utilizadores da página de internet da Revista Portuguesa de Cardiologia (RPC), é esta entidade, com sede no Campo Grande, n.º 28, 13.º, 1700-093 Lisboa, com os telefones 217 970 685 e 217 817 630, fax 217 931 095 e com o endereço de correio eletrónico revista@spc.pt. Declaro para todos os fins, que assumo inteira responsabilidade pela veracidade e exatidão da afirmação aqui fornecida.